GSK Invests $800M in PA Biopharma Hub
GSK plans to invest over 800 million dollars to expand its Pennsylvania site into a major biopharmaceutical hub. The project will create more than 300 jobs and support the production of biologic medicines.
Xurve View
Insights:
Xurve View
GSK PLC-SPON ADR will invest $800 million to expand its Pennsylvania site into a biopharma hub, adding 300 jobs. The project combines manufacturing and research in Montgomery County, backed by state tax incentives. The facility will accelerate commercial production of biologic medicines over the next five years.
